Eliminating malaria - All of them by Baird, J

Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria by Baird, J

Radical cure: the case for anti-relapse therapy against all malarias. by Baird, J

The currency of assessments by Baird, J

Editorial by Baird, J

Resistance to therapies for infection by Plasmodium vivax. by Baird, J

Elimination therapy for the endemic malarias. by Baird, J

“Lively” invasive Plasmodium vivax causes severe and complicated malaria by Baird, J

Neglect of Plasmodium vivax malaria. by Baird, J

Methylene blue-mediated hexose monophosphate shunt stimulation in human red blood cells in vitro: independence from intracellular oxidative injury. by Baird, J

Age-dependent characteristics of protection v. susceptibility to Plasmodium falciparum. by Baird, J

Elimination therapy for the endemic malarias by Baird, J

Age and 'strain-transcending' immunity to Plasmodium falciparum. by Baird, J

Primaquine toxicity forestalls effective therapeutic management of the endemic malarias. by Baird, J

Chemotherapeutics challenges in developing effective treatments for the endemic malarias by Baird, J

Reinventing primaquine for endemic malaria. by Baird, J

Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria. by Baird, J

Assessment and attitude by Baird, J

Do we need marking at all? by Baird, J

Editorial by Baird, J